StockData
Xencor Inc logo

Xencor Inc (XNCR) stock

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.50−0.90 (-2.54%)

Close on Nov 17, 2026Market cap $2.57BP/E –Yield –

Xencor enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Xencor's enterprise value was $3.03B on Nov 11, 2026, against $1.34B a year earlier. Over the last 5 years it ranged from $673.55M to $3.03B, with a median of $1.41B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.03B+153.2%
2025Dec 31, 2025$1.20B-31.5%
2024Dec 31, 2024$1.75B+41.5%
2023Dec 29, 2023$1.24B-17.9%
2022Dec 30, 2022$1.50B-34.7%
2021Dec 31, 2021$2.30B+17.7%
2020Dec 31, 2020$1.96B+39.4%
2019Dec 31, 2019$1.40B-20.3%
2018Dec 31, 2018$1.76B+114.9%
2017Dec 29, 2017$819.31M-16.3%
2016Dec 30, 2016$978.47M+111.0%
2015Dec 31, 2015$463.83M+4.9%
2014Dec 31, 2014$442.11M–
2013Dec 31, 2013-$1.65M–

More Xencor figures

See a number that looks wrong?